Middle East Tech Today: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Middle East Tech Today.

Press releases published on July 7, 2026

Jul. 7, 2026

Aquestive Therapeutics to Participate in Leerink Partners Therapeutics Forum: I&I and Metabolism

Indeterminate GlobeNewswire

Jul. 7, 2026

Endogenex Announces Full Enrollment of the ReCET Clinical Study

Indeterminate GlobeNewswire

Jul. 7, 2026

Tvardi Therapeutics’ TTI-109 Phase 1 Study Confirms Prodrug Design, Improved Tolerability and Pharmacodynamic Evidence of STAT3 Target Engagement

Indeterminate GlobeNewswire

Jul. 7, 2026

Avalo Therapeutics to Participate in the Leerink Partners Therapeutics Forum

Indeterminate GlobeNewswire

Jul. 7, 2026

Fredonia Provides El Dorado Monserrat Project and Corporate Update

Indeterminate GlobeNewswire

Jul. 7, 2026

Nuvini Retires R$61 Million Debenture Facility in Full

Indeterminate GlobeNewswire

Jul. 7, 2026

Kymera Therapeutics Appoints Elizabeth Laws, Ph.D., as Senior Vice President, Global Program Team Leader for KT-621, First-in-Class, Oral STAT6 Degrader

Indeterminate GlobeNewswire

Jul. 7, 2026

ImageneBio Appoints Matt Robbins as General Counsel

Indeterminate GlobeNewswire

Jul. 7, 2026

U.S. FDA Grants Priority Review to Agios’ sNDA for Mitapivat in Sickle Cell Disease

Indeterminate GlobeNewswire

Jul. 7, 2026

VR completes 2,900 ft hole and polyphase vein intersection at its New Boston Moly-Tungsten-Copper-Silver Porphyry Project in Nevada; core scanning and continuous geochemistry are underway

Indeterminate GlobeNewswire

Jul. 7, 2026

Stallion Uranium Defines Priority Target Areas from VTEM Survey on Stone Island Target, Moonlite Project

Indeterminate GlobeNewswire

Jul. 7, 2026

Axsome Therapeutics Initiates FOCUS-2 Phase 3 Trial of Solriamfetol in Children with Attention Deficit Hyperactivity Disorder (ADHD)

Indeterminate GlobeNewswire

Jul. 7, 2026

Aeluma CEO to Chair Optica Advanced Photonics Congress Industry Program on AI and Quantum

Indeterminate GlobeNewswire

Jul. 7, 2026

Annovis Reaches Full Enrollment in Pivotal Phase 3 Trial of Buntanetap for Early Alzheimer’s Disease

Indeterminate GlobeNewswire

Jul. 7, 2026

WRAP Launches WrapShield: An Autonomous Defense & Public Safety Platform, Beginning with Advanced Thermal Polarimetric Sensing for Counter-UAS and Expanding Across AI-Enabled Security Responses

Indeterminate GlobeNewswire

Jul. 7, 2026

OKYO Pharma to Participate in a Fireside Chat at Piper Sandler 2026 Virtual Ophthalmology Symposium

Indeterminate GlobeNewswire

Jul. 7, 2026

Kailera Therapeutics Announces Positive Topline Data from Two Hengrui Pharma Phase 3 Clinical Trials of Oral Small Molecule GLP-1 Receptor Agonist HRS-7535/KAI-7535

Indeterminate GlobeNewswire

Jul. 7, 2026

Orezone Provides 2026 Guidance for Casa Berardi

Indeterminate GlobeNewswire

Jul. 7, 2026

Semnur Pharmaceuticals, Inc. (“Semnur”), a Majority-Owned Subsidiary of Scilex Holding Company (Nasdaq: SCLX, “Scilex”), Announces Signing of Binding Term Sheet for Proposed $100 Million Strategic Investment from iHolding Group LLP

Indeterminate GlobeNewswire

Jul. 7, 2026

Jitterbit Appoints Chris Stoddard as Chief Revenue Officer to Drive Global Growth, Scale Accountable AI Adoption

Indeterminate GlobeNewswire